Juliang Qin

879 total citations · 1 hit paper
22 papers, 597 citations indexed

About

Juliang Qin is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Juliang Qin has authored 22 papers receiving a total of 597 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 10 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Juliang Qin's work include Adenosine and Purinergic Signaling (7 papers), Immune cells in cancer (6 papers) and CAR-T cell therapy research (5 papers). Juliang Qin is often cited by papers focused on Adenosine and Purinergic Signaling (7 papers), Immune cells in cancer (6 papers) and CAR-T cell therapy research (5 papers). Juliang Qin collaborates with scholars based in China, United States and France. Juliang Qin's co-authors include Bing Du, Min Qian, Mingyao Liu, Hua Ren, Binghe Tan, Xiaoyu Zhang, Na Zhang, Stefan Siwko, Honghui Han and Kendra S. Carmon and has published in prestigious journals such as The Journal of Immunology, Cancer Cell and Cancer Research.

In The Last Decade

Juliang Qin

20 papers receiving 590 citations

Hit Papers

CAR-T therapy in solid tumors 2025 2026 2025 10 20 30 40
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. CAR-T therapy in solid tumors
    2025 44 citations Bing Du, Juliang Qin et al. Cancer Cell profile →

Peers

Juliang Qin
Juha P. Laurila Finland
Cameron S. Field New Zealand
Donald W. Lawrence United States
Sarah Sargin Germany
Tulip Nandu United States
Takako Akiyama Japan
Jiang-Zhou Yu United States
John Meshki United States
Rie Kinoshita Japan
Zhongbin Bai Japan
Juha P. Laurila Finland
Juliang Qin
Citations per year, relative to Juliang Qin Juliang Qin (= 1×) peers Juha P. Laurila

Countries citing papers authored by Juliang Qin

Since Specialization
Citations

This map shows the geographic impact of Juliang Qin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juliang Qin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juliang Qin more than expected).

Fields of papers citing papers by Juliang Qin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juliang Qin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juliang Qin. The network helps show where Juliang Qin may publish in the future.

Co-authorship network of co-authors of Juliang Qin

This figure shows the co-authorship network connecting the top 25 collaborators of Juliang Qin. A scholar is included among the top collaborators of Juliang Qin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juliang Qin. Juliang Qin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Xiaohong, Yue Sun, Xinyue Lu, et al.. (2025). Pan-cancer analysis identifies CD155 as a promising target for CAR-T cell therapy. Genome Medicine. 17(1). 64–64. 1 indexed citations
2.
Tan, Binghe, Yongqian Xu, Ruijie Yang, et al.. (2025). GITRL enhances cytotoxicity and persistence of CAR-T cells in cancer therapy. Molecular Therapy. 33(6). 2789–2800. 3 indexed citations
3.
Qin, Juliang, et al.. (2025). Allogeneic CAR-T cell therapy in autoimmune diseases. Immunotherapy. 17(15). 1129–1143.
4.
Du, Bing, et al.. (2025). CAR-T therapy in solid tumors. Cancer Cell. 43(4). 665–679. 44 indexed citations breakdown →
5.
Qin, Juliang, Ying Qian, Chenshen Huang, et al.. (2024). FFAR2 expressing myeloid-derived suppressor cells drive cancer immunoevasion. Journal of Hematology & Oncology. 17(1). 9–9. 24 indexed citations
6.
Zhao, Yihan, Yingying Wang, Tianyun Fu, et al.. (2023). Identification and characterization of colorectal-cancer-associated SNPs on the SMAD7 locus. Journal of Cancer Research and Clinical Oncology. 149(18). 16659–16668. 3 indexed citations
7.
Zhang, Na, Xiaohong Liu, Juliang Qin, et al.. (2023). LIGHT/TNFSF14 promotes CAR-T cell trafficking and cytotoxicity through reversing immunosuppressive tumor microenvironment. Molecular Therapy. 31(9). 2575–2590. 40 indexed citations
8.
Chen, Jie, Ran Zhang, Juliang Qin, et al.. (2022). UDP/P2Y6 contributes to enhancing LPS-induced acute lung injury by regulating neutrophil migration. Cellular Immunology. 376. 104530–104530. 4 indexed citations
9.
Zhang, Su, Binghe Tan, Chenshen Huang, et al.. (2022). Neuroendocrine Regulation of Stress‐Induced T Cell Dysfunction during Lung Cancer Immunosurveillance via the Kisspeptin/GPR54 Signaling Pathway. Advanced Science. 9(13). e2104132–e2104132. 22 indexed citations
10.
Zhang, Xiaoyu, Wenxiang Zhao, Yihan Zhao, et al.. (2021). Inflammatory macrophages exacerbate neutrophil-driven joint damage through ADP/P2Y1 signaling in rheumatoid arthritis. Science China Life Sciences. 65(5). 953–968. 12 indexed citations
11.
Zhang, Chengfei, Juliang Qin, Su Zhang, et al.. (2020). ADP/P2Y1 aggravates inflammatory bowel disease through ERK5-mediated NLRP3 inflammasome activation. Mucosal Immunology. 13(6). 931–945. 25 indexed citations
12.
Qin, Juliang, Zhen Zhang, Hua Ren, et al.. (2020). The UDP/P2y6 axis promotes lung metastasis of melanoma by remodeling the premetastatic niche. Cellular and Molecular Immunology. 17(12). 1269–1271. 17 indexed citations
13.
Cheng, Long, Jiajia Pan, Lili Chen, et al.. (2020). Regulatory role of Gpr84 in the switch of alveolar macrophages from CD11blo to CD11bhi status during lung injury process. Mucosal Immunology. 13(6). 892–907. 20 indexed citations
14.
Qin, Juliang, Xiaoyu Zhang, Binghe Tan, et al.. (2020). Blocking P2X7-Mediated Macrophage Polarization Overcomes Treatment Resistance in Lung Cancer. Cancer Immunology Research. 8(11). 1426–1439. 63 indexed citations
15.
Pei, Haixiang, Juliang Qin, Binghe Tan, et al.. (2019). Discovery of potent ureido tetrahydrocarbazole derivatives for cancer treatments through targeting tumor-associated macrophages. European Journal of Medicinal Chemistry. 183. 111741–111741. 13 indexed citations
16.
Wu, Nannan, Xuan-Nhi Nguyen, Li Wang, et al.. (2019). The interferon stimulated gene 20 protein (ISG20) is an innate defense antiviral factor that discriminates self versus non-self translation. PLoS Pathogens. 15(10). e1008093–e1008093. 41 indexed citations
17.
Tan, Binghe, Jie Zhang, Juliang Qin, et al.. (2018). Inhibition of Rspo-Lgr4 Facilitates Checkpoint Blockade Therapy by Switching Macrophage Polarization. Cancer Research. 78(17). 4929–4942. 132 indexed citations
18.
Qin, Juliang, Xiaoyu Zhang, Ziqiang Wang, et al.. (2017). Presenilin 2 deficiency facilitates Aβ-induced neuroinflammation and injury by upregulating P2X7 expression. Science China Life Sciences. 60(2). 189–201. 21 indexed citations
19.
Zhang, Xiaoyu, Juliang Qin, Binghe Tan, et al.. (2016). Extracellular ADP facilitates monocyte recruitment in bacterial infection via ERK signaling. Cellular and Molecular Immunology. 15(1). 58–73. 36 indexed citations
20.
Zhang, Xiaoyu, Juliang Qin, Yihan Zhao, et al.. (2015). Long-term ketogenic diet contributes to glycemic control but promotes lipid accumulation and hepatic steatosis in type 2 diabetic mice. Nutrition Research. 36(4). 349–358. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Juha P. Laurila Breakdown of academic impact, for papers by Cameron S. Field Breakdown of academic impact, for papers by Donald W. Lawrence Breakdown of academic impact, for papers by Sarah Sargin Breakdown of academic impact, for papers by Tulip Nandu Breakdown of academic impact, for papers by Takako Akiyama Breakdown of academic impact, for papers by Jiang-Zhou Yu Breakdown of academic impact, for papers by John Meshki Breakdown of academic impact, for papers by Rie Kinoshita Breakdown of academic impact, for papers by Zhongbin Bai
Rankless by CCL
2026